Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests virtual coaching to improve life after cancer treatment

NCT ID NCT04428905

First seen Mar 01, 2026 · Last updated Jun 22, 2026 · Updated 15 times

Summary

This phase III trial is testing whether a telehealth self-management program can improve care coordination and quality of life for survivors of non-small cell lung cancer or colorectal cancer. About 403 participants who finished treatment 4 months ago will receive coaching sessions, a personalized care plan, and resources. The study compares their outcomes to those receiving standard attention, measuring communication with doctors and confidence in survivorship care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

telehealth self-management program

What this could lead to

If successful, this program could help cancer survivors feel more confident about follow-up care and improve communication with their doctors.

What could go wrong

This is a behavioral intervention, not a new drug or cure. Results depend on patient engagement and may not apply to all survivors.

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.